Hematological defects in the oc/oc mouse, a model of infantile malignant osteopetrosis
- PMID: 15284856
- DOI: 10.1038/sj.leu.2403449
Hematological defects in the oc/oc mouse, a model of infantile malignant osteopetrosis
Abstract
Infantile malignant osteopetrosis (IMO) is a rare and lethal disease characterized by an absence of bone resorption due to inactive OCLs. Affected patients display an increased bone mass and hematological defects. The osteopetrotic oc/oc mouse displays a bone phenotype similar to the one observed in IMO patients, and the same gene, Tcirg1, is mutated in this model and in the majority of these patients. Therefore, we explored in oc/oc mice the consequences of the perturbed bone microenvironment on hematopoiesis. We show that the myelomonocytic differentiation is increased, leading to an elevated number of OCLs and dendritic cells. B lymphopoiesis is blocked at the pro-B stage in the bone marrow of oc/oc mouse, leading to a low mature B-cell number. T-cell activation is also affected, with a reduction of IFNgamma secretion by splenic CD4(+) T cells. These alterations are associated with a low IL-7 expression in bone marrow. All these data indicate that the lack of bone resorption in oc/oc mice has important consequences in both myelopoiesis and lymphopoiesis, leading to a form of immunodeficiency. The oc/oc mouse is therefore an appropriate model to understand the hematological defects described in IMO patients, and to derive new therapeutic strategies.
Similar articles
-
Interleukin-7 partially rescues B-lymphopoiesis in osteopetrotic oc/oc mice through the engagement of B220+ CD11b+ progenitors.Exp Hematol. 2006 Jul;34(7):851-9. doi: 10.1016/j.exphem.2006.04.003. Exp Hematol. 2006. PMID: 16797412
-
Establishment and characterization of new osteoclast progenitor cell lines derived from osteopetrotic and wild type mice.Bone. 2006 Jul;39(1):53-60. doi: 10.1016/j.bone.2005.12.078. Epub 2006 Feb 28. Bone. 2006. PMID: 16503212
-
Nonablative neonatal bone marrow transplantation rapidly reverses severe murine osteopetrosis despite low-level engraftment and lack of selective expansion of the osteoclastic lineage.J Bone Miner Res. 2010 Sep;25(9):2069-77. doi: 10.1002/jbmr.90. J Bone Miner Res. 2010. PMID: 20568230
-
[Osteopetrosis, from mouse to man].Med Sci (Paris). 2004 Jan;20(1):61-7. doi: 10.1051/medsci/200420161. Med Sci (Paris). 2004. PMID: 14770365 Review. French.
-
Human osteopetrosis and other sclerosing disorders: recent genetic developments.Calcif Tissue Int. 2001 Jul;69(1):1-6. doi: 10.1007/s002230020046. Epub 2001 Jun 5. Calcif Tissue Int. 2001. PMID: 11685426 Review.
Cited by
-
OSTM1 bone defect reveals an intercellular hematopoietic crosstalk.J Biol Chem. 2008 Nov 7;283(45):30522-30. doi: 10.1074/jbc.M805242200. Epub 2008 Sep 11. J Biol Chem. 2008. PMID: 18790735 Free PMC article.
-
High bone mass in the STR/ort mouse results from increased bone formation and impaired bone resorption and is associated with extramedullary hematopoiesis.J Bone Miner Metab. 2013 Jan;31(1):71-81. doi: 10.1007/s00774-012-0394-9. Epub 2012 Nov 29. J Bone Miner Metab. 2013. PMID: 23192248
-
The road of NSCLC stem cells toward bone metastases.Bone Rep. 2022 Sep 5;17:101619. doi: 10.1016/j.bonr.2022.101619. eCollection 2022 Dec. Bone Rep. 2022. PMID: 36110341 Free PMC article.
-
The Bone Marrow Microenvironment in B-Cell Development and Malignancy.Cancers (Basel). 2022 Apr 22;14(9):2089. doi: 10.3390/cancers14092089. Cancers (Basel). 2022. PMID: 35565219 Free PMC article. Review.
-
The Bone's Role in Myeloid Neoplasia.Int J Mol Sci. 2020 Jul 1;21(13):4712. doi: 10.3390/ijms21134712. Int J Mol Sci. 2020. PMID: 32630305 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Research Materials